Benzoyl peroxide 5 % Topical Gel (28 GM) /salicylic acid 2 % Medicated Liquid Soap (127 GM) / salicylic acid 2 % Topical Solution (147 mL) Pack
RxNorm 1493509

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1493509 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: benzoyl peroxide 5 % Topical Gel (28 GM) /salicylic acid 2 % Medicated Liquid Soap (127 GM) / salicylic acid 2 % Topical Solution (147 mL) Pack.

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Benzoyl peroxide 5 % Topical Gel (28 GM) /salicylic acid 2 % Medicated Liquid Soap (127 GM) / salicylic acid 2 % Topical Solution (147 mL) Pack
AUI:7716434
View
GPCK
{1 (28000 mg) (benzoyl peroxide 0.05 mg/MG Topical Gel) / 1 (127000 mg) (salicylic acid 20 mg/ML Medicated Liquid Soap) / 1 (147 mL) (salicylic acid 20 mg/ML Topical Solution) } Pack
AUI:12372830
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSN

Prescribable Name (PSN):
Benzoyl peroxide 5 % Topical Gel (28 GM) /salicylic acid 2 % Medicated Liquid Soap (127 GM) / salicylic acid 2 % Topical Solution (147 mL) Pack
(Atom ID: 7716434)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
benzoyl peroxide 5 % Topical Gel (28 GM) /salicylic acid 2 % Medicated Liquid Soap (127 GM) / salicylic acid 2 % Topical Solution (147 ML) Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1493509
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
7716434
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1493509
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
GPCK

Generic Pack (GPCK):
{1 (28000 mg) (benzoyl peroxide 0.05 mg/MG Topical Gel) / 1 (127000 mg) (salicylic acid 20 mg/ML Medicated Liquid Soap) / 1 (147 mL) (salicylic acid 20 mg/ML Topical Solution) } Pack
(Atom ID: 12372830)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{1 (28000 MG) (benzoyl peroxide 0.05 MG/MG Topical Gel) / 1 (127000 MG) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (147 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1493509
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12372830
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
GPCK
Generic Pack ({# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack)
Source Code
1493509
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN HUMAN DRUG
US
Drug available for use in Humans

Patient Education

Benzoyl Peroxide Topical


Benzoyl peroxide is used to treat mild to moderate acne.
[Learn More]


Salicylic Acid Topical


Topical salicylic acid is used to help clear and prevent pimples and skin blemishes in people who have acne. Topical salicylic acid is also used to treat skin conditions that involve scaling or overgrowth of skin cells such as psoriasis (a skin disease in which red, scaly patches form on some areas of the body), ichthyoses (inborn conditions that cause skin dryness and scaling), dandruff, corns, calluses, and warts on the hands or feet. Topical salicylic acid should not be used to treat genital warts, warts on the face, warts with hair growing from them, warts in the nose or mouth, moles, or birthmarks. Salicylic acid is in a class of medications called keratolytic agents. Topical salicylic acid treats acne by reducing swelling and redness and unplugging blocked skin pores to allow pimples to shrink. It treats other skin conditions by softening and loosening dry, scaly, or thickened skin so that it falls off or can be removed easily.
[Learn More]


* Please review the disclaimer below.